Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration

Several molecular pathways are currently being targeted in attempts to develop disease-modifying therapies to slow down neurodegeneration in Parkinson’s disease. Failure of cellular energy metabolism has long been implicated in sporadic Parkinson’s disease and recent research on rare inherited forms...

Descripción completa

Detalles Bibliográficos
Autores principales: Quansah, Emmanuel, Peelaerts, Wouter, Langston, J. William, Simon, David K., Colca, Jerry, Brundin, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968614/
https://www.ncbi.nlm.nih.gov/pubmed/29793507
http://dx.doi.org/10.1186/s13024-018-0260-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968614/
https://www.ncbi.nlm.nih.gov/pubmed/29793507
http://dx.doi.org/10.1186/s13024-018-0260-x

Ejemplares similares